Predictive Oncology Inc.
(POAI)
undefined
undefined%
At close: undefined
1.85
-2.12%
Pre-market Jan 07, 2025, 05:45 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -13.98M | -25.74M | -19.66M | -25.88M | -19.39M | -10.09M | -7.75M | -6.53M | -4.79M | -6.83M | -9.41M | -7.42M | -4.49M | -1.35M | -2.89M | -1.76M |
| Depreciation & Amortization | 739.32K | 1.31M | 1.34M | 1.02M | 704.88K | 147.63K | 71.56K | 82.36K | 78.57K | 63.04K | 148.76K | 1.08K | 3.17K | 2.43K | 3.04K | 569.00 |
| Stock-Based Compensation | n/a | 522.44K | 921.13K | 1.17M | 2.74M | 1.46M | 4.04M | 886.60K | 871.88K | 835.42K | 3.94M | 4.75M | n/a | n/a | 355.12K | n/a |
| Other Working Capital | -729.75K | 964.82K | -725.17K | 468.08K | 1.27M | 650.20K | -1.01M | 917.40K | -2.50M | 1.40M | 812.37K | 1.04M | 70.34K | -1.32M | -4.00K | -39.60K |
| Other Non-Cash Items | 452.82K | 11.19M | 1.17M | 13.81M | 8.08M | 3.77M | 359.13K | 1.62M | -6.67K | 1.07M | 4.20M | 4.81M | 2.71M | -190.91K | 1.01M | 611.13K |
| Deferred Income Tax | n/a | -522.44K | -661.66K | -1.17M | -2.74M | n/a | -1.84K | n/a | 246.20K | n/a | n/a | n/a | n/a | n/a | 11.44K | n/a |
| Change in Working Capital | -397.56K | 866.69K | -1.19M | -1.21M | 1.87M | 884.30K | -1.18M | 446.00K | -3.89M | 2.33M | 1.21M | 1.43M | -5.84K | 720.51K | 197.66K | 250.41K |
| Operating Cash Flow | -13.19M | -12.37M | -12.21M | -12.26M | -8.73M | -5.29M | -4.46M | -4.38M | -7.49M | -3.37M | -3.86M | -1.18M | -1.78M | -820.68K | -1.31M | -900.53K |
| Capital Expenditures | -302.37K | -475.70K | -962.32K | -360.78K | -26.61K | -232.00K | -55.27K | -44.75K | -60.56K | -121.24K | -216.12K | n/a | n/a | n/a | n/a | -41.86K |
| Acquisitions | n/a | n/a | -9.59M | 193.32K | 248.10K | n/a | n/a | -11.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -3.08M | -850.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 244.97K | 284.67K | 571.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -26.02K | -55.83K | -55.00K | 193.32K | -820.58K | -1.12M | -1.88M | -88.01K | -28.09K | -19.83K | -53.35K | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -302.37K | -475.70K | -10.61M | -167.46K | -599.09K | -1.11M | -1.65M | -422.86K | -60.56K | -121.24K | -216.12K | n/a | n/a | n/a | n/a | -41.86K |
| Debt Repayment | 150.41K | n/a | -5.24M | 1.29M | 1.54M | 2.19M | n/a | n/a | -683.07K | 1.20M | 1.82M | 378.52K | 509.23K | 490.47K | -83.58K | -28.13K |
| Common Stock Repurchased | -1.51K | -27.65K | -11.53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 4.39M | 1.71M | 2.14M | 650.06K | 1.30M | n/a | 18.95K | 2.06M | n/a | n/a | n/a | 103.33K | 321.36K | -163.33K |
| Financial Cash Flow | 148.90K | 6.72M | 50.34M | 12.95M | 9.32M | 5.79M | 5.11M | 1.71M | 12.39M | 3.41M | 4.16M | 1.07M | 1.90M | 813.43K | 862.78K | 1.40M |
| Net Cash Flow | -13.34M | -6.13M | 27.52M | 527.50K | -11.32K | -604.04K | -997.90K | -3.09M | 4.84M | -85.57K | 88.81K | -109.85K | 113.60K | -7.25K | -447.21K | 459.66K |
| Free Cash Flow | -13.49M | -12.85M | -13.17M | -12.62M | -8.76M | -5.52M | -4.52M | -4.43M | -7.55M | -3.49M | -4.07M | -1.18M | -1.78M | -820.68K | -1.31M | -942.38K |